Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI WW FrankfurtCPhI WW Frankfurt
Not Confirmed
Not Confirmed
28-30 October, 2025
Not Confirmed
Not Confirmed
15-18 September, 2025
Not Confirmed
Not Confirmed
15-18 September, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI WW FrankfurtCPhI WW Frankfurt
Industry Trade Show
Not Confirmed
28-30 October, 2025
Industry Trade Show
Not Confirmed
15-18 September, 2025
Industry Trade Show
Not Confirmed
15-18 September, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/50-years-of-innovation-mikart-s-legacy-and-what-s-next-in-cdmo-excellence
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/global-api-micronization-market-set-to-surge-49-by-2030-led-by-specialized-industry-pioneers
11 Aug 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/180-life-sciences-announces-closing-of-private-offering-of-approximately-156-million-of-convertible-notes-302526399.html
01 Jul 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/biotechnology/180-life-sciences-corp.-announces-strengthening-of-legacy-intellectual-property-asset-1044620
01 May 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/180-life-sciences-corp.-announces-notice-of-allowance-for-u.s.-patent-1022250
30 Apr 2025
// ACCESSWIRE
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/180-life-sciences-corp.-announces-share-repurchase-1021585
27 Dec 2024
// ACCESSWIRE
https://www.accesswire.com/960392/180-life-sciences-corp-announces-pricing-of-29-million-registered-direct-offering-and-concurrent-private-placement-priced-at-the-market-under-nasdaq-rules
12 Dec 2024
// ACCESSWIRE
https://www.accesswire.com/953814/180-life-sciences-corp-regains-full-compliance-with-nasdaq-continued-listing-rules
ABOUT THIS PAGE